NuShores Biosciences LLC

NuShores’ vision is to improve the quality of life for people globally and to compete successfully in the bone and tissue regenerative materials industry. Early studies suggest that NuShores’ licensed, patented technology could deliver improved solutions for bone regeneration while cutting healthcare costs, lowering treatment risks and reducing healing times.  Research results show that NuShores’ NuCress™ scaffold could offer a number of benefits that to date not achieved by currently marketed bone regeneration products, therefore promising to bring better treatment outcomes to millions of people with severe bone injuries. NuShores has the exclusive, global license from University of Arkansas Little Rock to commercialize university owned patented and patent-pending technologies